Apotex Corp.

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: IPO T: - FT: IPO	A: 849999984 MR: - FA: 849999984 FAN: 849999984	D: 2026-06-16 FD: 2026-06-16	3 investors
2	RT: IPO T: - FT: IPO	A: 1300000080 MR: - FA: 1300000080 FAN: 1300000080	D: 2026-06-09 FD: 2026-06-09	-
3	RT: Initial Public Offering (IPO) T: - FT: Initial Public Offering (IPO)	A: 1300000000 MR: - FA: approximately 1.3 billion FAN: 1300000000	D: 2026-06-08 FD: 2026-06-08	5 investors
4	RT: IPO T: - FT: IPO	A: 1000000000 MR: - FA: approximately $1 billion (gross proceeds); ~$850 million to the Company (treasury offering) FAN: 1000000000	D: 2026-06-01 FD: 2026-06-01	-

IPO Latest

2026-06-16

$850.0M

3 investors (Pro only)

IPO 2026-06-09

$1.3B

Initial Public Offering (IPO) 2026-06-08

$1.3B

View 3 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

J

Jeff Watson

President & CEO

A

Ariel Alon

Chief Operations Officer

B

Barry Fishman

Chief Corporate Development Officer

B

Brian McClelland

Chief Financial Officer

C

Carina Vassilieva

Chief Human Resources Officer

C

Christine Baeder

President, Apotex USA and LATAM

View 14 more team members with Pro

Unlock Full Team Directory

Recent News

Apotex Corp. Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised